SION-719 is the first NBD1 stabilizer being evaluated in people living with cystic fibrosis Topline data expected in mid-2026 WALTHAM, Mass., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc ...
SION-719 is the first NBD1 stabilizer being evaluated in people living with cystic fibrosisTopline data expected in ...
Background Many observational studies highlight clonal haematopoiesis (CH) as a novel determinant of cardiovascular disease ...
Discover how high-field NMR enables detailed structural analysis of therapeutic oligonucleotides, including stereoisomer ...
AZoLifeSciences on MSN
Advances in Gene Silencing and Editing for Rare Disorders
Significant advancements in gene silencing and gene editing offer new hope for treating rare disorders. Techniques like RNA ...
Scientists at ETH Zurich have unveiled MetaGraph, a revolutionary new tool that's being called a 'Google for DNA'. This amazing innovation makes it su ...
In a major advance for biotechnology and bioinformatics, researchers from ETH Zurich have developed MetaGraph, a search ...
LONDON, GREATER LONDON, UNITED KINGDOM, October 13, 2025 /EINPresswire.com/ -- What Is The Expected Cagr For The Long‑Read Sequencing Services Market Through 2025? The market size for long-read ...
A new tool developed at, MetaGraph, allows scientists to search through vast public DNA and RNA databases in seconds — like a ...
Researchers from Wuhan University of Science and Technology and the Changchun Institute of Applied Chemistry, Chinese Academy of Sciences have jointly published a paper in Research entitled ...
In a groundbreaking study using Merino sheep, researchers uncovered that tiny genetic variations within gut microbes can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback